By Catherine J. Frompovich On June 2, 2011, The New York Times posted an online editorial that caught my eye, “The High Cost of Cheap Meat,” in which small doses of antibiotics in animal feed were discussed as the probable cause of the growing concern over an ineffectiveness in eliminating bacterial ‘super bugs’ that are […]
India: deadly drug trials
By Jason Overdorf A $400 million market for clinical trials puts desperate Indian patients at risk. CHENNAI, India — India’s huge population, many of whom have hardly been exposed to medication, makes it one of the world’s most promising markets for drug research. But as the $400 million business accelerates, critics say it is exposing […]
Beware the ghost(writer)s of medical research
By Dr. Marc-André Gagnon and Dr. Sergio Sismondo, Expert Advisors – EvidenceNetwork.ca OTTAWA, and KINGSTON, ON, June 16, 2011/ Troy Media/ – The medical research world has been concerned about the problem of ghostwriting for more than a decade. The issue has been repeatedly raised in the mainstream media over the past few years, with […]
Should we be rethinking the HPV vaccination strategy?
SciBlogs Infectious Thoughts Siouxsie Wiles Jun 22 A study just published in the Lancet suggests that Australia’s cervical cancer vaccination programme is already showing signs of success, with a decrease in the number of high-grade cervical abnormalities in vaccinated girls under 18. To quickly recap, the human papilloma virus (HPV) is a sexually transmitted infection […]
Demyelinating disease and vaccination of the human papillomavirus.
Mendeley Revista de Neurologia (2011) Volume: 52, Issue: 8, Pages: 472-476 by M J Alvarez-Soria, A Hernandez-Gonzalez, S Carrasco-Garcia De Leon, M A Del Real-Francia, M J Gallardo-Alcaniz, J L Lopez-Gomez ABSTRACT INTRODUCTION. Primary prevention by prophylactic vaccination against the major cause of cervical cancer, the carcinogenic human papillomavirus (HPV) types 16 and 18, is […]
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 199
- Next Page »
